Exposure to ayahuasca induces developmental and behavioral alterations on early life stages of zebrafish
Thayres S. Andrade, Rhaul Oliveira, Muriel Lopes Da Silva, Marcus Vinicius von Zuben, César Koppe Grisólia, Inês Domingues, Eloísa Dutra Caldas, Aline Pic‐taylor
Chemico-Biological Interactions August 4, 2018 DOI: 10.1016/j.cbi.2018.08.001 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | Zebrafish embryos and larvae |
| Intervention | Ayahuasca |
| Dose | 0 to 1000 mg/L |
| Duration | 96 h for toxicity and developmental endpoints; 120 and 144 h for locomotor activity |
| Topics | Ayahuasca |
| Keywords | Zebrafish Hatching Embryo Developmental toxicity Pharmacology |
| Citations | 31 |
| Key findings | Ayahuasca exposure caused developmental anomalies and decreased locomotor activity in zebrafish at high concentrations. |
Abstract
Ayahuasca is a psychoactive concoction prepared from the plants Banisteriopsis caapi and Psychotria viridis which are used ancestrally by Amazonian Indian populations and more recently, by Christian religious groups in Brazil and other countries. The aims of the present study were to identify the effects of ayahuasca on zebrafish embryo development and neurobehavior. Toxicity and developmental endpoints for zebrafish embryos were assessed from 0 to 1000 mg/L over 96 h of exposure. The effects on locomotor activity of zebrafish larvae were assessed using a video tracking system (ZebraBox) from 0 to 20 mg/L and after 120 and 144 h of exposure. The LC50 of ayahuasca in zebrafish was determined as 236.3 mg/L. Ayahuasca exposure caused significant developmental anomalies in zebrafish embryos, mainly at the highest concentration tested, including hatching delay, loss of equilibrium, edema and the accumulation of red blood cells. Embryo behavior was also significantly affected, with decreased locomotor activity at the highest concentration tested. These results are in accordance with data obtained in mammal studies highlighting the possible risks of uncontrolled use of ayahuasca. Further research employing more specific behavior analysis could provide additional data on both therapeutic benefits and possible toxicological risk of ayahuasca.
Comparable studies
Other preclinical and animal studies on ayahuasca, most cited first.
Citations in the library
Cited by 12
- Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats Metabolic Brain Disease February 27, 2020
- Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples. Molecules March 5, 2021
- Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review Medicines October 18, 2019
- Evaluation of the Cytotoxicity of Ayahuasca Beverages Molecules November 28, 2020
- The current state of ayahuasca research in animal models: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry July 13, 2023
and 7 more in the library
Cites 23
- Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report Brazilian Journal of Psychiatry March 1, 2015
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression Journal of Clinical Psychopharmacology December 11, 2015
- Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids Addiction December 20, 2006
- The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology March 2, 2016
- Ayahuasca: Pharmacology, neuroscience and therapeutic potential Brain Research Bulletin March 11, 2016
and 18 more in the library